January 10, 2025 03:59 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
8 labourers still trapped in Assam's flooded mine even after 3 days of rescue ops | SC refuses to hear petitions seeking review of its same-sex marriage judgement, says there is 'no error' | 'They should wind up the alliance': Omar Abdullah on AAP-Congress fight over Delhi elections | Pune woman killed by her colleague in full public view for not paying back his money, no one intervenes | Los Angeles wildfire leaves 5 dead, forces 1 lakh including celebs to flee, Hollywood hills ablazed | PM Modi condoles death of six people in Tirupati stampede incident | Days after condemning Pak airstrikes, India in a first engages with Afghanistan's Taliban regime | 6 dead in stampede near Tirupati temple during token distribution to offer prayers | Prominent journalist-film producer Pritish Nandy dies of cardiac arrest at 73 | Thousands, including Hollywood stars, flee Los Angeles upscale neighbourhood as wildfire engulfs homes
Glenmark introduces higher strength FabiFlu to reduce pill burden of COVID-19 treatment

Glenmark introduces higher strength FabiFlu to reduce pill burden of COVID-19 treatment

Aug 06, 2020, at 10:31 pm

Mumbai/UNI: Pharma major Glenmark announced on Thursday that it has introduced a 400 mg version of oral antiviral FabiFlu, for treating mild to moderate COVID-19 in India.

Glenmark slashes price of COVID-19 drug FabiFlu to Rs. 75 per tablet

Glenmark slashes price of COVID-19 drug FabiFlu to Rs. 75 per tablet

Jul 13, 2020, at 11:52 pm

Mumbai:  Glenmark Pharmaceuticals, a research-led, integrated global pharmaceuticalcompany, has announced a price reduction of 27% for COVID-19 drug FabiFlu.

India's Glenmark launches first oral antiviral drug FabiFlu to treat COVID-19 patients

India's Glenmark launches first oral antiviral drug FabiFlu to treat COVID-19 patients

Jun 21, 2020, at 01:23 pm

New Delhi/IBNS: Amid the massive spike in number of cases, India-based pharmaceutical company 'Glenmark Pharmaceuticals' has launched antiviral drug Favipiravir, to be sold under the brand name FabiFlu, for the treatment of patients having mild to moderate COVID-19 symptoms.

Glenmark to start new Phase 3 clinical trial on a combination of two anti-viral drugs in hospitalized patients of moderate COVID-19 in India

Glenmark to start new Phase 3 clinical trial on a combination of two anti-viral drugs in hospitalized patients of moderate COVID-19 in India

May 27, 2020, at 12:59 am

Mumbai/IBNS: Glenmark Pharmaceuticals, a pharmaceutical company, has announced a new randomized, open-label study to test thecombined efficacy of two antiviral drugs Favipiravir and Umifenovir as a potential COVID-19treatment strategy.